Rwandan health authorities have taken swift action following safety concerns surrounding antifungal tablets produced in Kenya.
The Rwanda Food and Drugs Authority (RFDA) issued a recall notice for all batches of 200 mg Fluconazole tablets manufactured by the Kenyan company Universal Corporation.
The directive, aimed at importers, mandates the return of these tablets due to discolouration issues discovered by the RFDA.
Specifically, four bulk batches of pink Fluconazole 200mg tablets showed white discolouration shortly after their shelf life began once imported into Rwanda.
Highlighting the urgency of the situation, the RFDA emphasized that some of these discoloured tablets had already entered the Rwandan market.
Consequently, retailers and health facilities have been instructed to cease distribution and return the affected drugs immediately.
As a precautionary measure, health officials in Rwanda have launched an investigation to ascertain whether these potentially compromised drugs have caused any adverse effects among consumers.
Amid these developments, Kenyan authorities are yet to announce whether the same antifungal drug, commonly used to treat fungal or yeast infections, will also undergo a recall within the local market.
Read: Ned Nwoke: Nigerians Should Be Allowed to Carry Guns
About The Author
Related Articles
NERC Moves To Raise Electricity Tariffs as Consumers Decry Paying For Darkness Instead Of Light
Nigerians are bracing for yet another round of electricity tariff increases, even...
ADC Chieftain Alleges N800 Billion FAAC Diversion By Tinubu Administration, Citing World Bank Report
The African Democratic Congress has raised serious allegations against the administration of...
After Eight-Year Hiatus Genevieve Nnaji Returns to Screen in BBC Studios Thriller ‘Wahala’
Nollywood icon Genevieve Nnaji is set to grace the screen once more,...
Ivory Coast Rushes to Calm Cocoa Farmer Protests as Unpaid Beans Rot and Crisis Spirals
The world’s top cocoa producer is rushing to defuse an escalating crisis...